Brain Cancer

In this video from the Annual Meeting of the American Neurological Association, David Gutmann, MD, PhD, FAAN, discusses the plenary session he co-chaired with Steven Small, MD, PhD, on microenvironment control of brain tumor pathogenesis.

City of Hope announced it has reached an agreement with Australia-based biotech Chimeric Therapeutics.

Today is Glioblastoma Awareness Day.

A modified natural killer T-cell therapy expressing a chimeric antigen receptor and interleukin-15 appeared feasible and safe for children with neuroblastoma, according to interim results of a first-in-human phase 1 trial presented at the virtual American Society of Gene and Cell Therapy Annual Meeting.

Risk for suicide appeared higher among individuals within the first year of a brain cancer diagnosis compared with the general population, according to a research letter published in JAMA Network Open.

National Brain Tumor Awareness Month is commemorated in May.

The FDA granted fast track designation to tozuleristide for treatment of pediatric central nervous system tumors.

Twelve institutions across the United States and Canada formed a collaborative designed to improve long-term survival and quality of life for patients with malignant brain tumors.

In this video, Tracy T. Batchelor, MD, head of the department of neurology at Brigham and Women's Hospital, discusses advances in imaging technologies for brain tumors.

In this video, Tracy T. Batchelor, MD, head of the department of neurology at Brigham and Women's Hospital, discusses how the location of a glioma can affect treatment options.